Ammo Inc. (Nasdaq: POWW) Board Authorizes Extension of Share Repurchase Plan

SCOTTSDALE, Ariz., March 28, 2023 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”), the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically integrated producer of high-performance ammunition and components, announces today that its Board of Directors approved an extension of the Company’s […]

SciSparc (Nasdaq: SPRC) completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million

Upon the closing which occurred on March 22, 2023, the purchase price was adjusted from $2.5 million and increased to approximately $3 million. TEL AVIV, Israel, March 28, 2023 (GLOBE NEWSWIRE) —  SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the […]

OKYO Pharma (NASDAQ: OKYO) To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4

Drug development isn’t known for being fast-paced, and developing any new drug is generally a long process. However, OKYO Pharma Ltd. (NASDAQ: OKYO) is moving quickly to develop its eye treatment drug, OK-101. It plans to begin trials for the drug in the 2nd quarter of 2023. OKYO Pharma is a biopharmaceutical company developing a treatment for […]

Jeffs’ Brands (Nasdaq: JFBR) Completes the Acquisition of a 49% interest in a Company that Owns Wellution, a Top Seller Brand on Amazon, for $3 million

Tel Aviv, Israel, March 28, 2023 (GLOBE NEWSWIRE) —  Jeffs’ Brands Ltd (the “Company” or “Jeffs’ Brands”) (Nasdaq: JFBR), a data-driven e-commerce company operating on the Amazon marketplace, today announced that it completed the purchase (the “Closing”) of approximately 49% of the outstanding capital stock of SciSparc Nutraceuticals Inc. ( “SciSparc Nutraceuticals”), a wholly-owned subsidiary […]

Splash Beverage Group’s (NYSE American: SBEV) Pulpoloco Available in 7-Eleven and Speedway Stores

FORT LAUDERDALE, FL, March 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, previously announced that Pulpoloco was awarded the 7-Eleven, Inc. Brands with Heart™ designation and with that designation the opportunity to showcase the brand to 7-Eleven® and Speedway® stores. The company […]

Laser Photonics (NASDAQ:LASE) to Host Exhibit Booth at Aviation Week MRO Americas 2023

ORLANDO, FL / ACCESSWIRE / March 23, 2023 / Laser Photonics Corporation (NASDAQ:LASE) (“LPC”), a leading global industrial developer of Cleantech laser systems for laser cleaning and other materials applications, today announced that it will be hosting an exhibit booth at Aviation Weekly’s MRO Americas 2023 tradeshow on April 18-20 at the Georgia World Congress Center in Atlanta, GA. “Laser Photonics […]

Mawson Infrastructure Group Reports Full Year 2022 Financial Results; Select Financial Highlights for FY 2022 compared to FY 2021

SHARON, Pa., March 23, 2023–(BUSINESS WIRE)–Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson”), a digital infrastructure provider, reports financial results and highlights for the fourth quarter and full year ended December 31, 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230323005164/en/ Q4 2022 Financial and Business Highlights Revenue of $16.8 million Gross profit of […]

OKYO Pharma (Nasdaq: OKYO) Announces PDMR Dealing

LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company“), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED“) to address the significant unmet need in this multi-billion-dollar market, today announces that it has been notified that Panetta Partners […]

atai Life Sciences (NASDAQ: ATAI) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights

NEW YORK and BERLIN, March 24, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, reported fourth quarter and full year 2022 financial results and provided clinical pipeline highlights. “With multiple clinical-stage programs aimed at addressing significant unmet patient needs in mental health […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.